We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Complications and Adverse Effects in Continuous Peripheral Regional Anesthesia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00251654
Recruitment Status : Completed
First Posted : November 10, 2005
Last Update Posted : October 1, 2009
Sponsor:
Collaborator:
Unfallklinik Murnau
Information provided by:
Rechbergklinik Bretten

November 9, 2005
November 10, 2005
October 1, 2009
January 2002
December 2008   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00251654 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Complications and Adverse Effects in Continuous Peripheral Regional Anesthesia
Complications and Adverse Effects in Continuous Peripheral Regional Anesthesia Results of Investigations on 3,491 Catheters
The investigators prospectively document infectious, neurological, and other complications or adverse events occurring during peripheral regional anesthesia via a catheter using computer-based data recording.
Perineural blocks with catheter placement are more and more frequently used. Few data dealing with infectious complications of perineural catheters exist. We assess incidence and localization of infectious complications of perineural catheters by means of computerized data acquisition. We prospectively evaluate perineural catheters placed at different sites for regional anesthesia and postoperative analgesia. The catheters were placed under standardized sterile conditions by using the nerve stimulator technique. Local inflammation is defined as the presence of at least two of the three signs: redness, pain on pressure or swelling. Infection is defined as the presence of at least two of the following criteria: pus at the catheter insertion site, fever, increased CRP and/or leukocytes requiring antibiotic therapy.
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
All patients receiving perineural blocks via catheter ASA 1 to 4
  • Infection
  • Inflammation
  • Adverse Effects
Procedure: perineural block (anesthesia)
continuous peripheral regional anesthesia ropivacaine 0.33% for 3 to 5 days
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
9000
December 2008
December 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • All patients receiving perineural blocks via catheter

Exclusion criteria:

Sexes Eligible for Study: All
1 Year and older   (Child, Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT00251654
MRA001
No
Not Provided
Not Provided
Dr. M. Neuburger, OrtenauKlinikum Achern
Rechbergklinik Bretten
Unfallklinik Murnau
Study Chair: Johannes Büttner, MD Unfallklinik Murnau
Rechbergklinik Bretten
September 2009